Meiji Seika Pharma Launches COPD Treatment Oxis, Detailed by More Than 600 MRs

September 4, 2012
Meiji Seika Pharma on September 3 launched its chronic pulmonary disease (COPD) treatment Oxis 9 μg Turbuhaler 28 Doses (formoterol fumarate hydrate). The NHI price was set at 1,660.00 yen per kit. Peak sales are forecasted at 4.2 billion yen...read more